Synthesis and evaluation of 1,2,4-triazolo[1,5-c]pyrimidine derivatives as A2A receptor-selective antagonists. 2010

Bidhan A Shinkre, and T Santhosh Kumar, and Zhan-Guo Gao, and Francesca Deflorian, and Kenneth A Jacobson, and William C Trenkle
Chemical Biology Unit, Laboratory of Cell Biology and Biochemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bldg 8, Rm 121, NIH, NIDDK, LCBB, Bethesda, MD 20892-0810, United States.

Movement disorders such as Parkinson's disease and Huntington's disease are serious life-limiting and debilitating movement disorders. Their onset typically occurs from mid-life to late in life, and effective diagnostic techniques for detecting and following the disease course are lacking. Our goal is to develop receptor imaging agents for positron emission tomography (PET) that selectively target the most relevant subtype of adenosine receptors (AR) that are highly expressed in the striatum, that is, the A(2A) AR. To further this goal, we have synthesized and characterized pharmacologically a family of high affinity A(2A) AR ligands, based on the known antagonist, SCH 442416 (R=-Me), which have structural variability on the terminus (R=-Et, -i-Pr, -allyl, and others). A O-fluoroethyl analogue suitable for use as a PET tracer had a K(i) value of 12.4 nM and was highly selective for the A(2A) AR in comparison to the A(1) and A(3) ARs.

UI MeSH Term Description Entries
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D003287 Contrast Media Substances used to allow enhanced visualization of tissues. Radiopaque Media,Contrast Agent,Contrast Agents,Contrast Material,Contrast Materials,Radiocontrast Agent,Radiocontrast Agents,Radiocontrast Media,Agent, Contrast,Agent, Radiocontrast,Agents, Contrast,Agents, Radiocontrast,Material, Contrast,Materials, Contrast,Media, Contrast,Media, Radiocontrast,Media, Radiopaque
D005462 Fluorine Radioisotopes Unstable isotopes of fluorine that decay or disintegrate emitting radiation. F atoms with atomic weights 17, 18, and 20-22 are radioactive fluorine isotopes. Radioisotopes, Fluorine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole
D017434 Protein Structure, Tertiary The level of protein structure in which combinations of secondary protein structures (ALPHA HELICES; BETA SHEETS; loop regions, and AMINO ACID MOTIFS) pack together to form folded shapes. Disulfide bridges between cysteines in two different parts of the polypeptide chain along with other interactions between the chains play a role in the formation and stabilization of tertiary structure. Tertiary Protein Structure,Protein Structures, Tertiary,Tertiary Protein Structures

Related Publications

Bidhan A Shinkre, and T Santhosh Kumar, and Zhan-Guo Gao, and Francesca Deflorian, and Kenneth A Jacobson, and William C Trenkle
April 1996, Farmaco (Societa chimica italiana : 1989),
Bidhan A Shinkre, and T Santhosh Kumar, and Zhan-Guo Gao, and Francesca Deflorian, and Kenneth A Jacobson, and William C Trenkle
February 2009, Bioorganic & medicinal chemistry letters,
Bidhan A Shinkre, and T Santhosh Kumar, and Zhan-Guo Gao, and Francesca Deflorian, and Kenneth A Jacobson, and William C Trenkle
November 2005, Bioorganic & medicinal chemistry letters,
Bidhan A Shinkre, and T Santhosh Kumar, and Zhan-Guo Gao, and Francesca Deflorian, and Kenneth A Jacobson, and William C Trenkle
October 2013, Archiv der Pharmazie,
Bidhan A Shinkre, and T Santhosh Kumar, and Zhan-Guo Gao, and Francesca Deflorian, and Kenneth A Jacobson, and William C Trenkle
August 2004, Journal of medicinal chemistry,
Bidhan A Shinkre, and T Santhosh Kumar, and Zhan-Guo Gao, and Francesca Deflorian, and Kenneth A Jacobson, and William C Trenkle
February 2004, Farmaco (Societa chimica italiana : 1989),
Bidhan A Shinkre, and T Santhosh Kumar, and Zhan-Guo Gao, and Francesca Deflorian, and Kenneth A Jacobson, and William C Trenkle
March 2005, Journal of medicinal chemistry,
Bidhan A Shinkre, and T Santhosh Kumar, and Zhan-Guo Gao, and Francesca Deflorian, and Kenneth A Jacobson, and William C Trenkle
November 1999, Journal of medicinal chemistry,
Bidhan A Shinkre, and T Santhosh Kumar, and Zhan-Guo Gao, and Francesca Deflorian, and Kenneth A Jacobson, and William C Trenkle
March 1996, Journal of medicinal chemistry,
Bidhan A Shinkre, and T Santhosh Kumar, and Zhan-Guo Gao, and Francesca Deflorian, and Kenneth A Jacobson, and William C Trenkle
May 2004, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!